Journals / Anestezi Dergisi / 2013 / Cilt: 21 - Sayı: 2

Transcatheter aortic valve implantation and anaesthesia

Transkateter aortik kapak implantasyonu ve anestezi

Pages
71–81
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Therefore, in this review; while TAVI procedure is examined in detail, the challenges from the aspect of anesthesiologists; pre, intra and postoperatively will be emphasized.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Recently, Transcatheter Aortic Valve Implantation (TAVI) has been a new technique for elder population with severe symptomatic aortic stenosis; who carry a high risk for surgery or are ineligible for conventional surgical aortic valve replacement.
📊
Key Findings & Data:The anesthesiologist plays a fundamental role in this new environment.
💡
Conclusion & Impact:Therefore, in this review; while TAVI procedure is examined in detail, the challenges from the aspect of anesthesiologists; pre, intra and postoperatively will be emphasized.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Recently, Transcatheter Aortic Valve Implantation (TAVI) has been a new technique for elder population with severe symptomatic aortic stenosis; who carry a high risk for surgery or are ineligible for conventional surgical aortic valve replacement. The anesthesiologist plays a fundamental role in this new environment. Therefore, in this review; while TAVI procedure is examined in detail, the challenges from the aspect of anesthesiologists; pre, intra and postoperatively will be emphasized.

Özet

Son yıllarda Transkateter Aortik Kapak İmplantasyonu (TAVİ) ciddi aort stenozu olan, cerrahi riski çok yüksek veya ameliyat edilemez yaşlı popülasyon için uygulanan yeni bir yöntemdir. Anesteziyologlar, bu yeni girişimlerde oldukça önemli roller almaktadır. Bu nedenle bu derlemede; TAVİ işlemi detaylı bir şekilde incelenirken, hasta güvenliği için anesteziyologların preoperatif, intraoperatif ve postoperatif dönemde dikkat etmesi gereken konular vurgulanacaktır.

🔖

Cite This Article

GÜMÜŞ, T., KESİMCİ, E. (2013). Transcatheter aortic valve implantation and anaesthesia. Anestezi Dergisi, Cilt: 21 - Sayı: 2, 71–81. https://ajindex.com/articles/165753

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease: Cardiovascular Health Study. J Am Coll Cardiol. 1997; 29: 630-634. 2.Jamieson WR, Edwards FH, Schwartz M, Bero JW, Clark RE, Grover FL. Risk stratification for cardiac valve replacement. National Cardiac Surgery Database. Database Committee of The Society of Thoracic Surgeons. Ann Thorac Surg 1999; 67: 943-951. 3.Billings F.T., Kodali S.K., Shanewise J.S. Transcatheter Aortic Valve Implatation: Anesthetic Considerations. Anaesthesia-Analgesia 2009; 108(5): 1453-1462. 4.Andersen HR, Knudsen LL, Hasemkam JM. Transluminal implantation of artificial heart valves: Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. Eur Heart J 1992; 13: 704- 708. 5.Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous trans-catheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002; 106: 3006-3008. 6.Webb J, Cribier A. Percutaneous transarterial aortic valve implantation: what do we know? Eur Heart J. 2011; 32: 140-147. 7.Johansson M., Nozohoor S., Kimblad PO., Harnek J., Olivecrona GK, Sjogren J. Transapical versus transfemoral aortic valve implantation: a comparison of survival and safety. Ann Thorac Surg. 2011; 91: 57-63. 8.Ewe SH, Delgado V, Ng AC, et al. Outcomes after transcatheter aortic valve implantation: transfemoral versus transapical approach. Ann Thorac Surg. 2011; 92: 1244-1251. 9.Taramasso M, Maisano F, Cioni M, Denti P, Godino C, Montorfano M,. Trans-apical and trans-axillary percutaneous aortic valve implantation as alternatives to the femoral route: short- and middle term results. Eur J Cardiothorac Surg 2011; 40; 49-55. 10. Petronio AS, De Carlo M, Bedogni F, et al. Safety and efficacy of the subclavian approach for transcatheter aortic valve implantation with the CoreValve revalving system. Circ Cardiovasc Interv 2010; 3: 359-366. 11. Covello RD, Landoni G, Zangrillo A. Anesthetic management of transcatheter aortic valve implantation. Curr Opin Anaesthesiol. 2011 Aug; 24(4): 417-425. 12. Mack MJ. Risk scores for predicting outcomes in valvular heart disease: how useful? Curr Cardiol Rep. 2011; 13: 107-112. 13. Piazza N, Wenaweser P, Van Gameren M. Relationship between the logistic EuroSCORE and the society of thoracic surgeons predicted risk of mortality score in patients implanted with the CoreValve System: